Loading your page…
Each register with its number of medicines and a few of them.
PHARMAC · 5 medicines
FDA · 5 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 3 medicines
Anvisa · 1 medicine
AIFA · 1 medicine
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Diazoxide | United States | 50MG/ML | suspension | Marketed | E5 Pharma INC |
| Diazoxide | United States | 15MG/ML | injectable | Not marketed | Abraxis Pharm |
| Proglycem | United States | 50MG/ML | suspension | Marketed | Teva Branded Pharm |
| Hyperstat | United States | 15MG/ML | injectable | Not marketed | Schering |
| Proglycem | United States | 100MG, 50MG | capsule | Not marketed | Teva Branded Pharm |
| Vykat XR | United States | 150MG, 25MG, 75MG | tablet, extended release | Marketed | Soleno Therap |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AIFA, Anvisa, CBG-MEB, FDA, Health Canada and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
